More recently, Han et al. reported the identification of a novel subset of CD14+CTLA-4+ regulatory dendritic cells in HCC patients, which suppresses antitumor immune response through CTLA-4-dependent IL-10 and indoleamine-2,3-dioxygenase (IDO) production23. Here, CTLA4 is linked to hepatocellular carcinoma.